A protective surface protein from type V group B streptococci shares N-terminal sequence homology with the alpha C protein

Infection by group B streptococci (GBS) is an important cause of bacterial disease in neonates, pregnant women, and nonpregnant adults. Historically, serotypes Ia, Ib, II, and III have been most prevalent among disease cases; recently, type V strains have emerged as important strains in the United States and elsewhere. In addition to type-specific capsular polysaccharides, many GBS strains possess surface proteins which demonstrate a laddering pattern on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and resistance to trypsin digestion. These include the alpha C protein, the R proteins, and protein Rib. Some of these proteins elicit protective antibodies in animals. We demonstrate a trypsin-resistant laddering protein purified from a type V GBS strain by mutanolysin extraction and column chromatography. This protein contains a major 90-kDa band and a series of smaller bands spaced approximately 10 kDa apart on SDS-PAGE. Cross-reactivity of the type V protein with the alpha C protein and with R1 was demonstrated on Western blot (immunoblot). N-terminal sequence analysis of the protein revealed residue identity with 17 of 18 residues at corresponding positions on the alpha protein. Western blot of SDS extracts of 41 clinical type V isolates with rabbit antiserum to the protein demonstrated a homologous protein in 25 isolates (61%); two additional strains exhibited a heterologous pattern which was also demonstrated with 4G8, a monoclonal antibody directed to the alpha C protein repeat region. Rabbit antiserum raised to the type V protein conferred protection in neonatal mice against a type V strain bearing a homologous protein. These data support the hypothesis that there exists a family of trypsin-resistant, laddering GBS surface proteins which may play a role in immunity to GBS infection.

[1]  D. Kasper,et al.  Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. Brisson,et al.  Structural and Immunochemical Characterization of the Type VIII Group B Streptococcus Capsular Polysaccharide (*) , 1996, The Journal of Biological Chemistry.

[3]  A. Schuchat,et al.  Invasive group B streptococcal disease: the emergence of serotype V. , 1996, The Journal of infectious diseases.

[4]  D. Kasper,et al.  Immunogenicity and protective activity in animals of a type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. , 1995, The Journal of infectious diseases.

[5]  L. Harrison,et al.  Emergence of serotype V group B streptococcal infection among infants and adults. , 1995, Journal of Infectious Diseases.

[6]  M. Wagner,et al.  JM9 strains, a new type of group B streptococci from Japan. , 1994, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

[7]  A. Schuchat,et al.  A population-based assessment of invasive disease due to group B Streptococcus in nonpregnant adults. , 1993, The New England journal of medicine.

[8]  G. Lindahl,et al.  Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections , 1993, The Journal of experimental medicine.

[9]  D. Kasper,et al.  Protection of neonatal mice from group B streptococcal infection by maternal immunization with beta C protein , 1992, Infection and immunity.

[10]  A. Schuchat,et al.  Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. , 1992, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[11]  F. Ausubel,et al.  Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Kasper,et al.  Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine , 1992, Infection and immunity.

[13]  D. Kasper,et al.  Neonatal mouse model of group B streptococcal infection. , 1992, The Journal of infectious diseases.

[14]  D. Kasper,et al.  Phenotypic diversity in the alpha C protein of group B streptococci , 1991, Infection and immunity.

[15]  F. Ausubel,et al.  Cloned alpha and beta C-protein antigens of group B streptococci elicit protective immunity , 1991, Infection and immunity.

[16]  D. Kasper,et al.  A monoclonal antibody identifies a protective C-protein alpha-antigen epitope in group B streptococci , 1991, Infection and immunity.

[17]  A. Hightower,et al.  Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. , 1990, The Journal of infectious diseases.

[18]  D. Kasper,et al.  Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. , 1990, The Journal of clinical investigation.

[19]  Y. Nishiyama,et al.  Antigenicity of group B Streptococcus strain "M9" and its prevalence in Japan. , 1990, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases.

[20]  P. Ferrieri,et al.  Molecular species of R-protein antigens produced by clinical isolates of group B streptococci , 1989, Journal of clinical microbiology.

[21]  D. Kasper,et al.  Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. , 1989, The New England journal of medicine.

[22]  P. Christensen,et al.  Correlation between low levels of maternal IgG antibodies to R protein and neonatal septicemia with group B streptococci carrying R protein. , 1983, International archives of allergy and applied immunology.

[23]  H. Wilkinson Comparison of streptococcal R antigens. , 1972, Applied microbiology.

[24]  G. Perlmann,et al.  PREPARATION AND PROPERTIES OF A PROTEIN (R ANTIGEN) OCCURRING IN STREPTOCOCCI OF GROUP A, TYPE 28 AND IN CERTAIN STREPTOCOCCI OF OTHER SEROLOGICAL GROUPS , 1952, The Journal of experimental medicine.